Navigation Links
STAAR Surgical to Purchase Canon's Interest in Japanese Joint Venture
Date:10/26/2007

Buy-Out for Cash and Preferred Stock Expected to Strengthen International

Growth Opportunities

MONROVIA, Calif, Oct. 26 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has entered into an agreement to acquire the interests of all other shareholders in Canon Staar Co., Inc., a joint venture that was formed by STAAR, Canon Inc. and Canon Marketing Japan, Inc. in 1988 to develop, manufacture and sell in Japan products using STAAR's technology. On the closing of the transaction the entity will be renamed STAAR Japan, Inc. and become a wholly owned subsidiary of STAAR.

At closing STAAR will pay to the Canon companies $4 million in cash and 1.7 million newly issued shares of Series A Convertible Preferred Stock, and will acquire the 50% interest in Canon Staar currently owned by the Canon companies. The Series A Convertible Preferred Stock will be convertible into common stock at a one-to-one ratio, and under certain circumstances will be redeemable for cash at $4 per share.

Canon Staar's current business consists of manufacturing and selling the Preloaded Injector, which is a silicone or acrylic intraocular lens packaged and shipped in a pre-sterilized, disposable injector ready for use in cataract surgery. Canon Staar is also currently seeking approval from the Japanese regulatory authorities to market in Japan STAAR's Visian(R) ICL(TM), Collamer(R) IOL and AquaFlow(R) Device. Canon Staar recorded worldwide sales of $10.4 million in fiscal year 2006.

At closing STAAR Japan will take over the intraocular lens distribution business currently op
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Indonesian boy with huge neck tumor was surgically removed
2. New spray gel heals surgical wounds
3. FDA approves surgical gel
4. Lower surgical volume linked to higher death rate
5. Sleep apnoea linked to surgical risks
6. Treatment Of Brain Aneurysms By A New Non-Surgical Approach
7. Complete Robotic Surgery To Revolutionize Surgical Treatment of Prostate Cancer
8. Surgeon Attempts to Create A Surgical Hernia Feat
9. Researchers Aim To Develop Next Generation Of Surgical Robots
10. Arrow Embedded In Tribal’s Chest For Two Weeks Surgically Remove
11. Surgical Intervention to Solve Obesity and Related Problems

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Specialist manufacturers who use medical lo... millions of dollars by bringing in technology par...ng numbers of pro-active medical manufacturers are...pt stage of their projects, ensuring that progress...ses or potentially outdated technology. , ...
(Date:11/26/2009)...K, Nov. 27 With cold and flu seaso... good practices to control the spread of infection...e not only to keep ourselves healthy, but to avoid...Finerty, RN, MS, CIC (certified in infection-contr...cupational health at Hospital for Special Surgery ...
(Date:11/26/2009)...ars, the number of Americans living with diabetes ...n 2009 to 44.1 million in 2034. Over the same peri...g from $113 billion to $336 billion, even with no ... based at the University of Chicago report in the ...of those with diabetes covered by Medicare will ri...
(Date:11/26/2009)...big or too heavy can lead to strains or worse , ...ere may be nothing wrong with stuffing your turkey...e same thing with your suitcase as you pack for ho...ated in 2008 in U.S. hospital emergency rooms, doc...s for luggage-related injuries, such as muscle str...
(Date:11/26/2009)... No more letters from the North Pole, Textsa... messages from Santa , No...perational efficiencies at the North Pole Santa Cl...dren all over the globe informed of his Christmas ...uo;s research department have identified a large a...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
... Therapy Appears Superior to Standard Therapy for ...omized, controlled trials comparing sequential and...nted, previously untreated H. pylori infection fo...irm these findings, 10-day sequential therapy coul...
... 19 Zimmer Holdings, Inc.,(NYSE: ZMH ; SWX: ZMH)...the,Company as Group President, Global Businesses....mer Dental, Zimmer Trauma, Zimmer Orthopaedic Surg...and Chief Executive Officer., "We are delighted t...
...tion Company Provides Development Expertise for Pa...lth Platform, PORTLAND, Ore., May 19 Mount Tabor...n and development company, announced,collaboration... headquarters today; the product allows users to s...
... polyalkylimide implant injections leaves skin ope...y 19 (HealthDay News) -- Cosmetic skin fillers cal...frequent, but sometimes severe, immune-related sid...ial features such as the lips, cheeks, forehead an...
...ing ED increased risk in diabetic men , , ...wo studies of men with diabetes add to the evidenc...y warning sign for serious heart disease. , A Hong...ly to have a heart attack or other major cardiac p...
...om University Hospitals Case Medical Center (UHCMC...der-- with malignant brain tumors are not treated ...s old. Furthermore, the researchers find that if ...pril issue of the Journal of Neurosurgery. , Usin...
Other Medicine News:Health News:Zimmer Holdings Names Mark C. Throdahl Group President, Global Businesses 2Health News:Zimmer Holdings Names Mark C. Throdahl Group President, Global Businesses 3Health News:Zimmer Holdings Names Mark C. Throdahl Group President, Global Businesses 4Health News:Mount Tabor Collaborates with Google Health 2Health News:Cosmetic Skin Fillers May Cause Delayed Side Effects 2Health News:Erectile Dysfunction a Strong Harbinger of Heart Trouble 2Health News:Erectile Dysfunction a Strong Harbinger of Heart Trouble 3Health News:Study: Patients 75 years and older with brain tumors may benefit from more aggressive treatment 2
(Date:11/25/2009)...A, Switzerland, Nov. 25 From Nove...novative hearing solutions, presented the second e...focusing on the special needs of the older populat...ts in aging and audiology from around the world an...older people with hearing loss for an opportunity ...
(Date:11/25/2009)..., Nov. 25 The FDA granted traditio...ets, a non-nucleoside reverse transcriptase inhibi...lly indicated for use in treatment-experienced adu...V-1 strains resistant to an NNRTI and other antire...s based on 48-week data from two Phase 3 studies k...
(Date:11/25/2009)...Md., Nov. 25 Remedium T...ream-like foam that stops severe bleeding, won fir...y Idea category of the Global Security Challenge 2...ted from more than 100 entries from around the wor... GSC Security Summit conference held at the London...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 1Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 2Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 3TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 1TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 2TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 3TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 4More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 1More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 2More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 3More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 4
...ical Company,Limited (Takeda) announced today that...ch & Development Center, Inc. (U.S.), submitted a ...ug Administration (FDA) for,marketing approval of ...l),("alogliptin/ACTOS") in a single tablet for the...scovered by Takeda,s wholly owned subsidiary, Take...
...er Supports Spiriva,s Safety,Profile, RIDGEFIELD,...m and Pfizer Inc have released a new analysis of 3... UPLIFT, confirming the long term,safety profile o...alation,powder). The new and expanded safety data ... article by Singh et al. published in the Septembe...
Other Medicine Technology:Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes 2Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes 3Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT 2Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT 3Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT 4Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT 5
Fineline EZ
Tendril DX Model 1388 K
Pediatric 6491
Flextend Model 4086
Medicine Products: